ArticleThe Journal of biological chemistry2026
Domain-specific functions of LRIT3 in synaptic assembly and retinal signal transmission.
Article in The Journal of biological chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
- Update of
Authors and funding
2 authors.
Funding
Abstract
LRIT3 is a leucine-rich repeat (LRR) protein that is expressed in the retina, and its absence causes complete congenital stationary night blindness (cCSNB), a genetically diverse disorder characterized by impaired low-light vision, myopia, and nystagmus. LRIT3 is expressed in rod and cone photoreceptors, and it transsynaptically organizes the assembly of the glutamate signaling complex, the signalplex, on depolarizing bipolar cells (DBCs). LRIT3 is a single-pass membrane protein with extracellular LRR, IG, and FN3 domains. We express domain deletion constructs using rAAV and examine the impact on LRIT3 trafficking, as well as the structural and functional recovery of the signalplex in DBCs. We show the LRR domain may be required for trafficking LRIT3 to the synapse in cones, but not rods, and it is needed for reassembly and function of the rod BC signalplex. The IG domain is required for the localization of TRPM1 to the signalplex and thus its function. The FN3 domain is not necessary for either DBC signalplex assembly or function. Our data demonstrate that the LRR and IG domains of LRIT3 are crucial for TRPM1 localization and retinal function, and that restoring Nyctalopin localization to the DBC signalplex alone is insufficient to restore TRPM1 expression. Based on our findings, we propose a model in which the LRR domain transsynaptically binds with Nyctalopin, while the IG domain interacts with TRPM1.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.